Von Willebrand Factor-Cleaving Protease Activity Remains at the Intermediate Level in Thrombotic Thrombocytopenic Purpura

Publisher： Karger

E-ISSN： 1421-9662|113|3|198-203

ISSN： 0001-5792

Source： Acta Haematologica, Vol.113, Iss.3, 2005-05, pp. : 198-203

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The von Willebrand Factor-Cleaving Protease (ADAMTS-13) and the Diagnosis of Thrombotic Thrombocytopenic Purpura (TTP)

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 33, Iss. 5-6, 2005-01 ,pp. : 417-421

Karger

Access to resources Recommend Favorite

Recombinant ADAMTS13 normalizes von Willebrand factor‐cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 9, Iss. 5, 2011-05 ,pp. : 936-944

John Wiley & Sons Inc

Access to resources Recommend Favorite

Imbalance of von Willebrand factor and its cleaving protease ADAMTS13 during systemic inflammation superimposed on advanced cirrhosis

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 1, 2015-01 ,pp. : 37-45

John Wiley & Sons Inc

Access to resources Recommend Favorite

Thrombotic Thrombocytopenic Purpura and Gemcitabine

By  

Case Reports in Oncology, Vol. 4, Iss. 1, 2011-03 ,pp. : 143-148

Karger

Access to resources Recommend Favorite

Rituximab and intermediate‐purity plasma‐derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor

By  

JOURNAL OF CLINICAL APHERESIS, Vol. 30, Iss. 1, 2015-02 ,pp. : 50-54

John Wiley & Sons Inc

Access to resources Recommend Favorite